Actemra 400 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FY8YC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,353
Award facts
- Contract value 100% obligated
- $19,352.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $19,352.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ACTEMRA 400 mg/20 mL vials. The contract, executed on August 6, 2025, with ultimate completion by August 7, 2025, represents a competitively awarded non-set-aside procurement with performance to be completed in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive global pharmaceutical support vehicle extending through December 2026 that enables the distributor to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems through the Defense Health Agency and other government entities. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical and medical supply requirements through open competition, with delivery orders consistently structured as firm fixed-price transactions. This specific delivery order for ACTEMRA, a specialty pharmaceutical product, exemplifies the company's ongoing role in supplying specialty medications and therapeutic agents to support military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DB25FY8YC?
SPE2DB25FY8YC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 6, 2025.
How much is contract SPE2DB25FY8YC worth?
The government has obligated $19,353 on SPE2DB25FY8YC.
Is contract SPE2DB25FY8YC an order under another contract?
Yes. SPE2DB25FY8YC is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY8YC competed?
The extent of competition for SPE2DB25FY8YC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award